Cue Biopharma (CUE) Stock Chart & Stock Price History $0.59 -0.04 (-6.35%) (As of 09/6/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Cue Biopharma Stock Price Performance5 Day Performance-18.34%1 Month Performance-13.25%3 Month Performance-60.14%6 Month Performance-70.05%Year-To-Date Performance-77.65%1 Year Performance-77.48% Receive CUE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << CUE Stock Chart for Saturday, September, 7, 2024 CUE Chart by TradingView Cue Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/06/2024$0.63$0.59-6.35%$0.66$0.56260,561 shs$28.70 million09/05/2024$0.66$0.63-4.66%$0.70$0.63191,671 shs$30.65 million09/04/2024$0.66$0.66+0.46%$0.68$0.64105,309 shs$32.14 million09/03/2024$0.72$0.66-8.96%$0.75$0.64254,620 shs$32.00 million09/02/2024$0.72$0.72$0.76$0.7243,400 shs$35.14 million08/30/2024$0.72$0.72+0.21%$0.76$0.7243,448 shs$35.15 million Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 08/29/2024$0.70$0.72+3.00%$0.75$0.71117,067 shs$35.07 million08/28/2024$0.73$0.70-3.99%$0.77$0.70173,530 shs$34.05 million08/27/2024$0.73$0.73-0.26%$0.77$0.70203,224 shs$35.47 million08/26/2024$0.77$0.73-5.00%$0.80$0.73204,595 shs$35.56 million08/23/2024$0.82$0.77-5.59%$0.86$0.75292,423 shs$37.43 million08/22/2024$0.91$0.82-9.94%$0.95$0.81314,979 shs$39.65 million08/21/2024$0.86$0.91+4.76%$1.00$0.89375,591 shs$44.03 million08/20/2024$0.76$0.86+13.68%$0.90$0.76514,027 shs$42.03 million08/19/2024$0.68$0.76+11.93%$0.78$0.65306,256 shs$36.97 million08/16/2024$0.59$0.68+14.33%$0.68$0.59192,423 shs$33.03 million08/15/2024$0.62$0.59-4.21%$0.67$0.58251,490 shs$28.89 million08/14/2024$0.63$0.62-2.21%$0.66$0.61120,822 shs$30.16 million08/13/2024$0.66$0.63-3.49%$0.68$0.62136,968 shs$30.84 million08/12/2024$0.64$0.66+3.29%$0.72$0.64149,338 shs$31.95 million08/09/2024$0.66$0.64-3.65%$0.72$0.63214,421 shs$30.94 million08/08/2024$0.68$0.66-2.94%$0.71$0.6577,717 shs$32.11 million08/07/2024$0.65$0.68+4.34%$0.72$0.6579,116 shs$33.08 million08/06/2024$0.73$0.65-10.72%$0.75$0.65198,590 shs$31.70 million08/05/2024$0.73$0.73+0.01%$0.75$0.63249,662 shs$35.51 million08/02/2024$0.78$0.73-5.82%$0.82$0.73203,699 shs$35.51 million08/01/2024$0.84$0.78-7.17%$0.87$0.76330,289 shs$37.70 million07/31/2024$0.77$0.84+9.15%$0.92$0.731.06 million shs$40.61 million07/30/2024$0.65$0.77+18.27%$0.93$0.655.68 million shs$37.21 million07/29/2024$0.67$0.65-3.46%$0.68$0.62379,713 shs$31.46 million07/26/2024$0.70$0.67-4.73%$0.73$0.67421,831 shs$32.59 million07/25/2024$0.70$0.70+1.05%$0.75$0.68196,236 shs$34.21 million07/24/2024$0.74$0.70-6.26%$0.76$0.69263,259 shs$33.86 million07/23/2024$0.77$0.74-3.58%$0.80$0.74232,611 shs$36.12 million07/22/2024$0.76$0.77+1.16%$0.81$0.75185,247 shs$37.46 million07/19/2024$0.83$0.76-8.10%$0.83$0.73494,916 shs$37.03 million07/18/2024$0.90$0.83-7.70%$0.90$0.83350,323 shs$40.29 million07/17/2024$0.93$0.90-3.70%$0.94$0.84442,410 shs$43.65 million07/16/2024$0.93$0.93+0.22%$0.98$0.92279,205 shs$45.33 million07/15/2024$0.94$0.93-1.08%$1.00$0.90183,671 shs$45.24 millionTim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade07/12/2024$0.95$0.94-0.85%$1.00$0.93309,613 shs$45.73 million07/11/2024$0.89$0.95+7.01%$0.96$0.85493,743 shs$46.13 million07/10/2024$0.93$0.89-4.71%$0.98$0.87456,536 shs$43.11 million07/09/2024$0.98$0.93-4.80%$0.98$0.93327,773 shs$45.24 million07/08/2024$0.96$0.98+1.76%$1.02$0.93543,489 shs$47.52 million07/05/2024$0.98$0.96-2.04%$1.07$0.96258,168 shs$46.70 million07/04/2024$0.98$0.98$1.09$0.97278,275 shs$47.67 million07/03/2024$1.08$0.98-9.26%$1.09$0.97278,275 shs$47.67 million07/02/2024$1.02$1.08+5.88%$1.13$1.03566,570 shs$52.53 million07/01/2024$1.24$1.02-17.74%$1.29$0.941.53 million shs$49.62 million06/28/2024$1.40$1.24-11.43%$1.44$1.244.05 million shs$60.31 million06/27/2024$1.38$1.40+1.45%$1.49$1.34267,043 shs$68.10 million06/26/2024$1.45$1.38-4.50%$1.58$1.38313,689 shs$67.12 million06/25/2024$1.47$1.45-1.70%$1.47$1.37325,371 shs$70.29 million06/24/2024$1.35$1.47+8.89%$1.49$1.37298,620 shs$71.50 million06/21/2024$1.30$1.35+3.85%$1.37$1.26331,752 shs$65.66 million06/20/2024$1.35$1.30-3.70%$1.43$1.30213,601 shs$63.23 million06/19/2024$1.35$1.35$1.42$1.26335,971 shs$65.66 million06/18/2024$1.34$1.35+0.75%$1.42$1.26335,961 shs$65.66 million06/17/2024$1.36$1.34-1.47%$1.42$1.32255,908 shs$65.18 million06/14/2024$1.54$1.36-11.69%$1.56$1.35362,856 shs$66.15 million06/13/2024$1.50$1.54+2.67%$1.65$1.47274,233 shs$74.91 million06/12/2024$1.47$1.50+2.04%$1.62$1.48239,462 shs$72.96 million06/11/2024$1.44$1.47+2.08%$1.48$1.37298,294 shs$71.50 million06/10/2024$1.48$1.44-2.70%$1.53$1.37356,062 shs$70.04 million06/07/2024$1.62$1.48-8.64%$1.62$1.47222,463 shs$71.99 million06/06/2024$1.65$1.62-1.82%$1.69$1.61114,113 shs$78.80 million Related Companies: Kodiak Sciences Stock Price Chart Cadrenal Therapeutics Stock Price Chart Cellectis Stock Price Chart Immunic Stock Price Chart Nuvectis Pharma Stock Price Chart Repare Therapeutics Stock Price Chart Atyr PHARMA Stock Price Chart Inventiva Stock Price Chart INmune Bio Stock Price Chart Senti Biosciences Stock Price Chart Receive CUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CUE) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.